Page 41 | Certara

Podcast

How Generative AI is Unlocking Insights to Expand Drug Development with Dr. Chris Bouton

In this podcast, Dr. Chris Bouton, Senior VP and Head of AI at Certara, highlights…

CertaraOctober 30, 2024

Publication

Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women

The article titled "Using PBPK modeling to supplement clinical data and support the safe and…

CertaraOctober 30, 2024

Guide

The Complete Guide to CDISC Standards Management

Learn how to easily manage and validate against CDISC data standards our complete guide to…

CertaraOctober 30, 2024

Announcement

Certara Announces New Head of Clinical Pharmacology & Translational Medical Group

RADNOR, PA – October 30, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraOctober 30, 2024

Publication

Quantitative systems pharmacology model of GITR-mediated T cell dynamics in tumor microenvironment

Abstract: T cell interaction in the tumor microenvironment is a key component of immuno-oncology therapy.…

CertaraOctober 29, 2024

Publication

Early Feasibility Assessment: A Method for Accurately Predicting Biotherapeutic Dosing to Inform Early Drug Discovery Decisions

Early Feasibility Assessment (EFA) can impact early drug discovery decisions such as determining feasibility of…

CertaraOctober 29, 2024

On-Demand Webinar

Early Feasibility Assessment: An Innovative Approach to Gain Confidence in Therapeutic Discovery

In this webinar Josh Apgar, PhD discusses Early Feasibility Assessment (EFA), a quantitative approach to early…

CertaraOctober 29, 2024

Brochure

Certara Environmental, Social, and Governance (ESG) Report

Explore how our ESG strategy is crafting impactful, lasting change in our ESG Report.

CertaraOctober 29, 2024

Press Release

Certara to Participate in the Stephens Annual Investment Conference

RADNOR, Pa. — October 28, 2024 -- Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraOctober 28, 2024

Press Coverage

Pharma Exec: MDMA Therapy for Mental Health Conditions

Certara's Dr. Fran Brown, SVP Drug Development Science, is featured in this recent Pharmaceutical Executive…

CertaraOctober 28, 2024

How Generative AI is Unlocking Insights to Expand Drug Development with Dr. Chris Bouton

Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women

The Complete Guide to CDISC Standards Management

Certara Announces New Head of Clinical Pharmacology & Translational Medical Group

Quantitative systems pharmacology model of GITR-mediated T cell dynamics in tumor microenvironment

Early Feasibility Assessment: A Method for Accurately Predicting Biotherapeutic Dosing to Inform Early Drug Discovery Decisions

Early Feasibility Assessment: An Innovative Approach to Gain Confidence in Therapeutic Discovery

Certara Environmental, Social, and Governance (ESG) Report

Certara to Participate in the Stephens Annual Investment Conference

Pharma Exec: MDMA Therapy for Mental Health Conditions

Newsletter sign up

Quick links

Solutions

Contact